DENVER--(BUSINESS WIRE)--The Colorado BioScience Association (CBSA) is releasing its annual edition of Bioscience Colorado, this week, at the BIO International Convention in San Diego, CA. The announcement is made by CBSA President & CEO April Giles, who says, “In this issue we are looking at the intersection of people and data, and how it benefits human health. Big Data is now playing a critical role within the bioscience industry—from the personal devices on our wrists monitoring our bodies, to electronic medical records housing our health histories—data is valuable.”
Bioscience Colorado is a key resource for companies, investors and economic developers, and has become the go-to source for the industry. With a total audience of over 8,000, including online impressions, this publication is one of the industry’s greatest voices—locally, nationally and internationally.
This new issue, Drawing People & Data Together to benefit human health, includes:
- Mobile Health in Colorado: Where “Big Data” Sparks Big Ideas
- Biodesix Harnesses Machine Learning and Analytics to Tackle Multivariate Diagnostics
- Bioscience in Colorado Continues to Shine with U.S. Senator Michael Bennet
- Colorado Life Science Assets: A Sophisticated Repertoire of Clinical-Stage Therapeutic, Device and Diagnostic Products
- Boettcher Investigators: Webb-Waring Biomedical Research Program
- Found in Translation: Rocky Mountain Lions Eye Institute Translational Research Programs Focus on Innovative Treatment of Eye Diseases
- Tech Transfer Offices Connect the Dots between Research and the Marketplace, Stimulate State’s Economy
- Colorado by the Numbers: Financing and Acquisitions
- Grant Programs: Innovation Engines
- Colorado Bioscience Industry Directory
The complete flip book of the issue can be found online at:
Bioscience Colorado is an integral part of the Association’s mission to support the Colorado bioscience community through advocacy, resources and advancement of opportunities for collaboration. It reaches thousands of bioscience, economic development, legislative, university and industry leaders.
Colorado’s bioscience assets are also valuable. Device, diagnostic and therapeutic products created here have a significant economic impact—27,000 in total workforce— translating to over $10 billion in the State’s economy each year. In addition, over 60 acquisitions, financings and grants, totaling over $4 billion, were reported within the 2013 calendar year, further developing the industry’s ecosystem.
“Companies in Colorado have created important life-saving drugs and devices. We are proud to have continually grown the industry here and are excited for what the future brings. Bioscience in Colorado truly is driving innovation, creating jobs and improving lives,” Giles concludes.
About Colorado BioScience Association
CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
CBSA also is found on these social media sites:
LinkedIn Group: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro
Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation